Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03099876
Recruitment Status : Unknown
Verified April 2017 by IL-YANG RA, Il-Yang Pharm. Co., Ltd..
Recruitment status was:  Recruiting
First Posted : April 4, 2017
Last Update Posted : April 7, 2017
Sponsor:
Information provided by (Responsible Party):
IL-YANG RA, Il-Yang Pharm. Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 1, 2017
Estimated Study Completion Date : December 1, 2018